Comparing EMG-Biofeedback and Rebound Therapy for Endometriosis Relief
Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis
This study is testing whether EMG-Biofeedback or Rebound Therapy can help women with endometriosis feel better and manage their symptoms more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | Female |
| Sponsor | Medipol University Academic / other |
| Locations | 1 site (Üsküdar, İstanbul) |
| Trial ID | NCT06517654 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of two different pelvic floor muscle strengthening approaches—EMG-Biofeedback and Rebound Therapy—on women diagnosed with endometriosis. Participants will be divided into three groups: one receiving EMG-Biofeedback, another undergoing Rebound Therapy, and a third performing home exercises. Over an 8-week period, various assessments will be conducted to evaluate pelvic floor muscle strength, pain levels, perceived stress, quality of life, and sleep quality. The study aims to provide insights into which method may offer better relief for endometriosis symptoms.
Who should consider this trial
Good fit: Ideal candidates are women aged 20-50 diagnosed with endometriosis and experiencing moderate to severe pain.
Not a fit: Patients currently receiving medical treatment for endometriosis or those with certain medical conditions affecting their participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide effective non-pharmacological treatment options for women suffering from endometriosis.
How similar studies have performed: While there is ongoing research in this area, the specific comparison of EMG-Biofeedback and Rebound Therapy for endometriosis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between 20-50 years old, * Being diagnosed with endometriosis, * Completing the voluntary consent form, * Pain level being at least 4 on the Visual Analog Scale (VAS). Exclusion Criteria: Exclusion Criteria for the EMG-Biofeedback Group: * Being included in another study during the study period, * Being receiving medical treatment for endometriosis, * Presence of gynecological bleeding, * Presence of communication and cooperation problems, * Presence of tubo-ovarian abscess, * Active vaginal or urinary tract infection, * Pregnancy and giving birth within the last 12 months, * Presence of impaired somatosensory status, * Not attending 2 consecutive sessions. Exclusion Criteria for the Rebound Therapy Group: In addition to the exclusion criteria determined for the EMG-Biofeedback Group; * Presence of a neurological or orthopedic disease affecting the lower extremity, * History of spine and/or lower extremity orthopedic surgery, * Presence of severe arthritis affecting the spine and/or lower extremity, * Presence of uncontrolled hypertension and cardiovascular disease.
Where this trial is running
Üsküdar, İstanbul
- Zeynep Kamil Women and Children's Diseases Training and Research Hospital — Üsküdar, İstanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: Çağla Özgören, Msc
- Email: cagla.ozgoren@medipol.edu.tr
- Phone: 5316267328
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.